Fight Kids Cancer & St Baldrick’s Foundation Arceci Innovation AwardFind out more
Fight Kids Cancer is an exciting new venture to cure all children and adolescents with cancer through the development of better targeted and less toxic therapies.
research projects: 7 clinical trials 23 translational research projects
disease areas supported by our research projects
European countries benefiting from our support over the 4 first years
The Fight Kids Cancer programme aims to catalyse and support pan-European innovative and relevant research initiatives in paediatric cancer to develop innovative research that improve the outcome for all children and adolescents with cancer.
The Fight Kids Cancer programme (hereafter “FKC”) aims to catalyse and support pan-European innovative and relevant research initiatives in paediatric cancer to develop innovative research that improves the outcome for all children and adolescents with cancer. Our calls cover the following non-exclusive objectives:
1. To realise real impact on young patients: Improve their survival rate and reduce toxicity to restore young patients to full health after treatment.
2. To advance cutting-edge science to further the knowledge of paediatric malignancies.
3. To support improved interdisciplinary knowledge, methods and collaborations for tackling the issues of today.
4. To strengthen collaboration and the development of scientific capacity across Europe. The FKC calls for projects aim towards overcoming the structural lack of research dedicated to paediatric cancers by ensuring a recurring endowment that will be granted to
the best European research projects every year. An additional ambition is to foster closer working ties between basic researchers and clinicians.
The Fight Kids Cancer programme funds both early phase clinical trials and translational research. We support innovative interventions or approaches towards novel treatment (such as innovative drugs, artificial intelligence, imaging, radiotherapy, surgical approaches…).The two categories of projects are:
1. Early Phase Clinical Trials to evaluate innovative therapies for children and adolescents with cancer. These trials must be conducted and financed in at least 2 European countries over 3 years or less. We particularly welcome innovative clinical trial design approaches.
2. Translational research projects addressing childhood and adolescent cancers. We strongly encourage multidisciplinary or multi-institution collaborations that lead to the identification of novel targets of action, new therapies or better models of disease. We require a clear pathway to a clinical trial but we accept high-risk / high return proposals.
A robust selection process
All applications for fundings are independently reviewed by international experts. The selection process is organised in two stages:
– A light application form or “Expression of interest”, reviewed by two independent reviewers based on the likelihood of (i) improving survival rate, (ii) improving quality of life during and after the treatments, (iii) improving our knowledge on cancer causes and treatment resistance and (iv) of resulting in a clinical trial.
– A full proposal, reviewed by two (translational) or three (clinical) independent reviewers that are experts in the field, and two panellists based on (i) their scientific excellence, (ii) the quality and efficiency of the implementation and (iii) the impact for patients (including societal / policy relevance and approaches to stakeholder engagement).
Programme support and management is provided by the European Science Foundation, which is the intermediary with the funding organisations.
For further information about this announcement of opportunity please contact Fight Kids Cancer at ESF: email@example.com